TP53 Status Determines Clinical Significance of ERBB2 Expression in Ovarian Cancer
British Journal of Cancer- United Kingdom
doi 10.1038/sj.bjc.6602238
Full Text
Abstract
Available in
Date
November 16, 2004
Authors
Publisher
Springer Nature
doi 10.1038/sj.bjc.6602238
Available in
November 16, 2004
Springer Nature